Editor s quote. " Journal of Hematology Oncology provides a forum for top-quality research and is a leading title in hematology and oncology with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an
Articles from Therapeutic Advances in Medical Oncology are provided here courtesy of SAGE Publications
2021-7-22 · Journal updates. The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal which is chiefly devoted to Original papers also includes Reviews as well as Editorials and Guest editorials on current controversial topics.
2019-6-3 · Abstract Background The use of adjuvant chemotherapy in patients with breast cancer may be guided by clinicopathological factors and a score based on
Latest Impact Factor announced. The latest Impact Factor for Neuro-Oncology has risen to 10.247. To celebrate we have curated a selection of highly cited articles contributing to the new Impact Factor and invite you to explore this collection. Read the collection. Advertisement.
Latest Impact Factor announced. The latest Impact Factor for Neuro-Oncology has risen to 10.247. To celebrate we have curated a selection of highly cited articles contributing to the new Impact Factor and invite you to explore this collection. Read the collection. Advertisement.
2017-6-1 · Journal of medical imaging and radiation oncology (ISSN 1754-9477 1754-9485)
Oncology Reports is an international journal devoted to fundamental and applied research in oncology.
Latest Impact Factor announced. The latest Impact Factor for Neuro-Oncology has risen to 10.247. To celebrate we have curated a selection of highly cited articles contributing to the new Impact Factor and invite you to explore this collection. Read the collection. Advertisement.
Editor s quote. " Journal of Hematology Oncology provides a forum for top-quality research and is a leading title in hematology and oncology with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an
IJMPOIP Int J Med Paediatr Oncol- Print ISSN No -2581-4699 Online ISSN No -2581-4702 IP International Journal of Medical Paediatrics and Oncology (IJMPO) open access peer-reviewed quarterly journal publishing since 2015 and is published under the Khyati Education and Research Foundation (KERF) is registered
2015-6-18 · February 02 2015. Clinicopathologic Characteristics and Management Trends of Cutaneous Invasive and In Situ Melanoma in Older Patients. The incidence of melanoma in
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies Sanmei Wang Leopold Sellner Lei Wang Tim Sauer Brigitte Neuber Wenjie Gong Sophia Stock Ming Ni Hao Yao Christian Kleist Anita Schmitt Carsten Müller‑Tidow Michael Schmitt Maria-Luisa Schubert
Editor s quote. " Journal of Hematology Oncology provides a forum for top-quality research and is a leading title in hematology and oncology with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an
Editor s quote. " Journal of Hematology Oncology provides a forum for top-quality research and is a leading title in hematology and oncology with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an
2021-7-21 · Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer from the more basic discoveries dealing with both cell and molecular biology of tumour cells to the most advanced clinical assays of conventional and new drugs.
2014-10-1 · Category med oncol Outcomes of hypercalcemia of malignancy in patients with solid cancer a national inpatient analysis. med oncol • September 19 2019. Who should be admitted to the intensive care unit The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
Major Research Areas. Clinical research Advanced radiotherapy techniques intensity modulated radiotherapy stereotactic radiotherapy using tomotherapy cyberknife and autosegmentation nasopharyngeal carcinoma especially its relationship with the Epstein Barr virus and immunotherapy including T cell treatment multimodality treatment that aims at improving control and minimising side
IJMPOIP Int J Med Paediatr Oncol- Print ISSN No -2581-4699 Online ISSN No -2581-4702 IP International Journal of Medical Paediatrics and Oncology (IJMPO) open access peer-reviewed quarterly journal publishing since 2015 and is published under the Khyati Education and Research Foundation (KERF) is registered
2018-4-16 · Inhibitors of programmed death 1 (PD-1) and its ligand PD-L1 are effective therapies for metastatic non–small-cell lung cancer (NSCLC) lacking sensitizing EGFR or ALK mutations. Pembrolizumab
2019-1-8 · Lancet Oncol 17 1497-1508 2016 Crossref Medline Google Scholar 18. Gandhi L Rodríguez-Abreu D Gadgeel S et al Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378 2078-2092 2018 Crossref Medline Google Scholar 19.
2014-10-1 · Category med oncol Outcomes of hypercalcemia of malignancy in patients with solid cancer a national inpatient analysis. med oncol • September 19 2019. Who should be admitted to the intensive care unit The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
2021-6-16 · Non–small-cell lung cancer is a major cause of death from cancer. The use of cytotoxic chemotherapy is associated with a response rate of 20 to 35 and a
Articles from Therapeutic Advances in Medical Oncology are provided here courtesy of SAGE Publications
Gynecologic Oncology is a part of Elsevier s Oncology Journal Network. As part of Article Advance Gynecologic Oncology ensures a fast seamless publication process and offers additional support from a dedicated editorial team. With Gynecologic Oncology indexed in Pubmed/Medline your published article is guaranteed maximum visibility.
2018-1-31 · N Engl J Med 377 338-351 2017 Crossref Medline Google Scholar 7. Gravis G Fizazi K Joly F et al Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15) A randomised open-label phase 3 trial. Lancet Oncol 14 149-158 2013 Crossref Medline Google Scholar 8.
2015-6-18 · February 02 2015. Clinicopathologic Characteristics and Management Trends of Cutaneous Invasive and In Situ Melanoma in Older Patients. The incidence of melanoma in
Med Oncol. 2017 Aug34(8) 132. doi 10.1007/s12032-017-0991-5. Epub 2017 Jun 26.
2017-5-8 · Clin. Oncol. 31 1806–1814 (2013). Engl. J. Med. 373 726–736 (2015). Article CAS PubMed PubMed Central Google Scholar 6. Singh R.R. et al. Clinical validation of a next-generation
BQ+ Medical not only produce components for manufacturers all over the world, but also provide private label manufacturing for leading brand distributors in different countries.
8,Cheye Road,Songjiang District,Shanghai 201611 China.
Tel: 86-021-57743953
Email: [email protected]
Copyright © BQ PLUS MEDICAL CO., LTDSitemap | Contact Us |
